The body weight and cholesterol levels of the mice were recorded before the administration of the drug. by Xueqin lu (22250795)

Effects of Kylo-0603 on body weight, organ weight, and body fat content. by Xueqin lu (22250795)

After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group. by Xueqin lu (22250795)

Pharmacological efficacy of Kylo-0603 in MASH mouse models (F2 ~ 3). by Xueqin lu (22250795)

The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention. by Xueqin lu (22250795)

Plasma cholesterol and LDL-C levels. by Xueqin lu (22250795)

Hematoxylin and eosin (H&E) staining, Sirius Red staining, and Oil Red staining of liver tissues from mice in each group after 8 weeks of treatment with either vehicle or Kylo-0603... by Xueqin lu (22250795)

Table_1_A phased intervention bundle to decrease the mortality of patients with extracorporeal membrane oxygenation in intensive care unit.pdf by Yajun Jing (11711139)

“…Among all the ECMO-related complications, the incidence of bloodstream infection and bleeding decreased significantly at 13–18 months after implementation compared with the baseline. …”

S1 Dataset - by Edosa Tesfaye Geta (16541924)

“…SDM significantly decreased the level of HbA1c by 0.14% (95% CI = -0.28, -0.01, P = 0.00) when shared decisions were made in person or face-to-face at the point of care, but there was no statistically significant reduction in HbA1c levels when patients were engaged in online SDM. …”

GXM decreases the trans-endothelial electrical resistance (TEER) and transmigration of <i>C</i>. <i>neoformans</i> through HBECs in a blood brain barrier (BBB) model. by Hiu Ham Lee (15374677)

IFiS scale of fitness in study participants (N = 200). by Uzair Abbas (18517982)

Table_1_Real-World data on efficacy of L-glutamine in preventing sickle cell disease-related complications in pediatric and adult patients.DOCX by Narcisse Elenga (3746569)

“…In a Phase 3 clinical trial, L-glutamine demonstrated a significant reduction in SCD-related complications including vaso-occlusive crises (VOCs), hospitalizations, and acute chest syndrome (ACS) compared to placebo in patients with SCD.…”

Corrected QT interval and RR interval relationships by correction method and individual study. by Xin Hui S. Chan (8537544)

Fig 2 - by Francesco Saverio Sorrentino (11512630)

SHOULD MALE CIRCUMCISION BE PROMOTED IN DEVELOPING COUNTRIES AS MAJOR MEANS OF HIV PREVENTION by Wazhma Hakimi.pdf by Wazhma Hakimi (8820506)

“…Whereas another follow-up study of MC acceptors showed significant reduction in engagement of circumcised men in nonmarital relations (Kong et al., 2012). …”

Supplementary Material for: Impact of Lung Biopsy on Lung Function in Idiopathic Pulmonary Fibrosis by Aussedat P.-H. (9711755)

“…A significant decrease was also observed after SLB in FEV1, TLC, and DLCO. …”

Table 1_Associations between the Dietary Inflammatory Index and depression among pregnant and postpartum women: analysis of NHANES 2005–2018.docx by Jian Qiao (26659)

“…Diets with very high proinflammatory potential were linked to significantly increased odds of perinatal depression, whereas more anti-inflammatory diets did not result in a further decrease in depression risk below that threshold. …”

Table_1_Fluid resuscitation strategy in patients with placenta previa accreta: a retrospective study.docx by Fan Zhou (196667)

“…Maternal SBP, DBP, and MAP started to decrease immediately after the baby was delivered and reached a relatively stable trough state at 15–30 min after delivery. …”

Image_1_Fluid resuscitation strategy in patients with placenta previa accreta: a retrospective study.TIFF by Fan Zhou (196667)

“…Maternal SBP, DBP, and MAP started to decrease immediately after the baby was delivered and reached a relatively stable trough state at 15–30 min after delivery. …”

Supplementary Material for: Retrospective Study of Transjugular Intrahepatic Portosystemic Shunt Placement for Cirrhotic Portal Hypertension by Santos S. (8951453)

“…Mean follow-up was 15.7 ± 15 months. First-month mortality was 11.7% (<i>n</i> = 6) (sepsis, <i>n</i> = 3; acute liver failure, <i>n</i> = 2; and recurrence of variceal bleeding, <i>n</i> = 1) and was significantly higher for patients with Child-Pugh >9 points (<i>p</i> = 0.01), model of end-stage liver disease (MELD) scores >19 (<i>p</i> = 0.02), and for patients with a history of HE before the procedure (<i>p</i> = 0.001). …”